Authors:
Sugiyama, N
Eguchi, S
Kawazoe, Y
Miyamoto, S
Kamohara, Y
Fujioka, H
Furui, J
Sato, M
Ishii, T
Kanematsu, T
Citation: N. Sugiyama et al., Intraportal administration of low-dose recombinant human hepatocyte growthfactor enhances effects of hepatocellular transplantation, HEP-GASTRO, 47(35), 2000, pp. 1245-1249
Authors:
Kamohara, Y
Fujioka, H
Eguchi, S
Kawashita, Y
Furui, J
Kanematsu, T
Citation: Y. Kamohara et al., Comparative study of bioartificial liver support and plasma exchange for treatment of pigs with fulminant hepatic failure, ARTIF ORGAN, 24(4), 2000, pp. 265-270
Authors:
Kawashita, Y
Ohtsuru, A
Fujioka, H
Kamohara, Y
Kawazoe, Y
Sugiyama, N
Eguchi, S
Kuroda, H
Furui, J
Yamashita, S
Kaneda, Y
Kanematsu, T
Citation: Y. Kawashita et al., Safe and efficient gene transfer into porcine hepatocytes using Sendai virus-cationic liposomes for bioartificial liver support, ARTIF ORGAN, 24(12), 2000, pp. 932-938
Authors:
Moriuchi, H
Fujioka, H
Gu, W
Eguchi, S
Kamohara, Y
Yamamoto, T
Azuma, T
Furui, J
Koji, T
Kanematsu, T
Citation: H. Moriuchi et al., Mechanisms of immunosuppressive effects of FK 506 in light of apoptosis ofhepatocytes and infiltrating lymphocytes in rat allografted livers, TRANSPLAN P, 32(7), 2000, pp. 2320-2321
Authors:
Kamohara, Y
Sugiyama, N
Mizuguchi, T
Inderbitzin, D
Lilja, H
Middleton, Y
Neuman, T
Demetriou, AA
Rozga, J
Citation: Y. Kamohara et al., Inhibition of signal transducer and activator transcription factor 3 in rats with acute hepatic failure, BIOC BIOP R, 273(1), 2000, pp. 129-135
Authors:
Fujioka, H
Eguchi, S
Sugiyama, N
Kawazoe, Y
Kawashita, Y
Kamohara, Y
Azuma, T
Furui, J
Kanematsu, T
Citation: H. Fujioka et al., Efficacy of Nafamostat Mesilate for improving the performance of a bioartificial liver using porcine hepatocytes, INT J ARTIF, 22(7), 1999, pp. 505-510
Authors:
Fujioka, H
Kawashita, Y
Kamohara, Y
Yamashita, A
Mizoe, A
Yamaguchi, J
Azuma, T
Furui, J
Kanematsu, T
Citation: H. Fujioka et al., Utility of technetium-99m-labeled-galactosyl human serum albumin scintigraphy for estimating the hepatic functional reserve, J CLIN GAST, 28(4), 1999, pp. 329-333
Authors:
Mizoe, A
Fujioka, H
Kamohara, Y
Watanabe, Y
Azuma, T
Kanematsu, T
Citation: A. Mizoe et al., The significance of measuring the serum total bile acids levels during orthotopic liver transplantation, HEP-GASTRO, 46(28), 1999, pp. 2454-2459
Authors:
Eguchi, S
Kamohara, Y
Sugiyama, N
Kawazoe, Y
Kawashita, Y
Tamura, H
Morishita, M
Miyamoto, S
Azuma, T
Fujioka, H
Furui, J
Kanematsu, T
Citation: S. Eguchi et al., Efficacy and current problems with a porcine hepatocyte-based bioartificial liver: Light and shade, TRANSPLAN P, 31(5), 1999, pp. 2014-2015
Authors:
Suh, KS
Lilja, H
Kamohara, Y
Eguchi, S
Arkadopoulos, N
Neuman, T
Demetriou, AA
Rozga, J
Citation: Ks. Suh et al., Bioartificial liver treatment in rats with fulminant hepatic failure: Effect on DNA-binding activity of liver-enriched and growth-associated transcription factors, J SURG RES, 85(2), 1999, pp. 243-250